Skip to main content
Clinical Trials/NCT01800279
NCT01800279
Completed
Not Applicable

Comparative Study on the Effectiveness of Physical Therapy and Deontology for Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome.

Universidad de Almeria1 site in 1 country70 target enrollmentMarch 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Temporomandibular Joint Dysfunction Syndrome
Sponsor
Universidad de Almeria
Enrollment
70
Locations
1
Primary Endpoint
Pain Intensity
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine whether kinesitherapy techniques and a myofascial therapy protocol are effective in the treatment of temporomandibular joint dysfunction in patients with fibromyalgia syndrome.

Detailed Description

Design: randomized clinical trial. Objective: to compare the therapeutic effects of physiotherapy and deontology protocol to improve pain, quality of life, physical function, quality of sleep, depression, anxiety, clinical severity, clinical improvement, and diagnostic criteria for research temporomandibular joint dysfunction in patients with fibromyalgia syndrome (FMS). Background: the results on physiotherapy benefits for temporomandibular joint dysfunction in patients with FMS are controversial. Descriptive data and intervention studies are still scarce. Methods and measures: sixty patients will be randomly assigned to experimental or control group. The experimental group will receive 24 sessions (twice a week) of kinesitherapy and myofascial release protocol, whereas the control group will undergo to deontology therapy (porting a deprogramming occlusal splint every night, an average of 8 hours per day, for 12 weeks of the treatment). Pain levels, impact of FMS symptoms, quality of sleep, depression, anxiety, clinical severity, clinical improvement and diagnostic criteria for research of temporomandibular joint dysfunction will be collected in both groups at baseline and 12 weeks after 48-hr the last intervention in the experimental and control groups, by an assessor blinded to the treatment allocation of the patients. Baseline demographic and clinical variables will be examined between both groups independent Student t-test for continuous data and χ2 tests of independence for categorical data. Separate 2x2 mixed model ANCOVAs with time (pre-post) as the within-subjects factor, group (experimental, control) will be to determine the effects of the treatment on pain, function, quality of sleep,depression, anxiety, clinical severity, clinical improvement and diagnostic criteria for research of temporomandibular joint dysfunction as the dependent variables.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
December 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Adelaida María Castro-Sánchez

PhD (Lecturer)

Universidad de Almeria

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of fibromyalgia syndrome.
  • Agreement to attend evening therapy sessions.
  • A chief complaint of acute pain (duration \<6 months) in the temporomandibular joint on at least one side.
  • The presence of joint clicking during jaw opening that was eliminated on protrusive opening.

Exclusion Criteria

  • History of recent trauma.
  • Therapeutic co-interventions during treatment.
  • Indication for surgical treatment of temporomandibular joint.
  • Edentulism.
  • Physical or mental illness that precludes attendance at therapy sessions.

Outcomes

Primary Outcomes

Pain Intensity

Time Frame: At baseline and 12 weeks

The visual analog scale (VAS), designed to measure the intensity of pain and degree of relief experienced by the patient; with the value 0 for pain-free and 100 for maximum pain.

Secondary Outcomes

  • Temporomandibular Dysfunction.(At baseline and 12 weeks)
  • Quality of Life (SF-36)(At baseline and 12 weeks)
  • Index of Widespread Pain and Symptom Severity(At baseline and 12 weeks)
  • Physical Function.(At baseline and 12 weeks)
  • Quality of Sleep.(At baseline and 12 weeks)
  • Rates of Depression(At baseline and 12 weeks)
  • State-Trait Anxiety.(At baseline and 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials